TipRanks
Go Ultimate55% OFF

Novo Nordisk (NVO) Stock Forecast & Price Target

15,174 Followers
See the Price Targets and Ratings of:

NVO Analyst Ratings

Hold
7Ratings
0Buy6Hold1Sell
Based on 7 analysts giving stock ratings to Novo Nordisk in the past 3 months

NVO Stock 12 Month Forecast

$42.53▲(5.83% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for Novo Nordisk in the last 3 months. The average price target is $42.53 with a high forecast of $47.00 and a low forecast of $40.00. The average price target represents a 5.83% change from the last price of $40.19.
Highest Price Target$47.00Average Price Target$42.53Lowest Price Target$40.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for NVO
Price TargetFollowArticle
Berenberg Bank$47hold16.94%UpsideReiterated10/13/26
BMO Capital$47→$40hold-0.47%DownsideReiterated10/12/26
Jefferies Analyst forecast on NVOUnknown AnalystNot RankedJefferies$42.20hold5.00%UpsideReiterated09/22/26
TD Cowen$42hold4.50%UpsideReiterated09/22/26
Morgan Stanley$40sell-0.47%DownsideDowngraded09/11/26
Argus Research―hold―Reiterated08/07/26
Goldman Sachs$48→$44hold9.48%UpsideReiterated08/06/26
Nordea Markets―hold―Downgraded02/24/26
Deutsche Bank ―hold―Downgraded02/23/26
HSBC$47→$54hold34.36%UpsideReiterated12/10/25
J.P. Morgan―buy―Reiterated11/24/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRVITrevi Therapeutics
EHCEncompass Health
MDWDMediwound
OVIDOvid Therapeutics
ONCBeOne Medicines

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Novo Nordisk

3 Months
Richard Vosser
Richard VosserJ.P. Morgan
Success Rate4/7 ratings generated profit
57%
Average Return
+0.86%

Copying Richard Vosser's trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +0.86% per trade.

1 Year
Richard Vosser
Richard VosserJ.P. Morgan
Success Rate4/7 ratings generated profit
57%
Average Return
+4.24%

Copying Richard Vosser's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +4.24% per trade.

2 Years
Richard Vosser
Richard VosserJ.P. Morgan
Success Rate4/7 ratings generated profit
57%
Average Return
+22.97%

Copying Richard Vosser's trades and holding each position for 2 Years would result in 57.14% of your transactions generating a profit, with an average return of +22.97% per trade.

NVO Analyst Recommendation Trends

05101520Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for NVO
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy00000
Buy00000
Hold68131516
Sell00011
Strong Sell00000
total68131617

In the current month, NVO has received 0 Buy Ratings, 16 Hold Ratings, and 1 Sell Ratings. NVO average Analyst price target in the past 3 months is 42.53.

NVO Financial Forecast

$-1$-0.25$0.5$1.25$2Q4 2025Q2 2026Q3 2026
High$0.80
Consensus$0.73
Low$0.68

NVO Earnings Forecast

Next quarter’s earnings estimate for NVO is $0.73 with a range of $0.68 to $0.80. The previous quarter’s EPS was $0.96. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$10.7B$11.8B$12.9B$14B$15.2BQ4 2025Q2 2026Q3 2026
High$11.8B
Consensus$11.1B
Low$10.7B

NVO Sales Forecast

Next quarter’s sales forecast for NVO is $11.08B with a range of $10.68B to $11.76B. The previous quarter’s sales results were $12.21B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

NVO Stock Forecast FAQ

What is NVO’s average 12-month price target, according to analysts?
Based on analyst ratings, Novo Nordisk’s 12-month average price target is $42.53.
What is NVO’s upside potential, based on the analysts’ average price target?
Novo Nordisk has 5.83% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is NVO a Buy, Sell or Hold?
Novo Nordisk has a consensus rating of Hold which is based on 0 buy ratings, 6 hold ratings and 1 sell ratings.
What is Novo Nordisk’s price target?
The average price target for Novo Nordisk is $42.53. This is based on 7 12-month price targets, issued in the past 3 months. The highest analyst price target is $47.00, the lowest forecast is $40.00. The average price target represents a 5.83% increase from the current price of $40.19.
What do analysts say about Novo Nordisk?
Novo Nordisk’s analyst rating consensus is a Hold. This is based on the ratings of 7 Wall Street analysts.
How can I buy shares of NVO?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.